Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib plus phototherapy in vitiligo
IRCT20240604062002N2Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tofacitinib in Vitiligo, sponsored by Tabriz University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20240604062002N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240604062002N2.